Engineering AAV Lead Vectors for Gene Therapy

Key Learning Objectives
The safety challenges of undersized and oversized rAAV vectors and design strategies to address them.
The impact of rAAV vector design on manufacturing productivity and batch potency.
The contribution of rAAV vector design to the therapeutic sequence expression level and persistence in the target tissue.
Audience
Head of Research and Development Viral Vectors
Head of Research and Development Gene therapy
Head of Research and Development Viral technology
Group Head Viral vectors
Group Head viral technology
Head of Discovery
Head of Development
Vector Biology and Discovery Lead